RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome

NCT03684564 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Antiphospholipid Syndrome
Systemic Lupus Erythematosus
Stroke
Ischemic Stroke
Brain Ischemia

Interventions

DRUG: Rivaroxaban
DRUG: Warfarin

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]